Experience
Actelion Pharmaceuticals
ICOS Corp.
Represents ICOS in two IPRs defending their formulation patents.
Actelion Pharmaceuticals v. ICOS Corp., IPR2015-00561, -00562, PTAB, Judges Mitchell, Snedden, Yang
Lupin Pharmaceuticals, Inc. v. Pozen Inc.
Horizon Pharma USA, Inc.; Pozen Inc.
IntelGenX Corporation v. Eli Lilly and Company; ICOS Corporation
Eli Lilly and Company; ICOS Corporation
Finnegan secures a non-institution decision at the PTAB for Health Diagnostic Laboratory
Health Diagnostic Laboratory, Inc,
Global Tel*Link Corp. v. Securus Technologies, Inc.
Securus Technologies, Inc.
Mylan Pharmaceuticals Inc. v. Senju Pharmaceutical Co., Ltd.
Senju Pharmaceutical Co., Ltd.; Bausch & Lomb Incorporated
Medicis Pharmaceutical Corp. v. Apotex, Inc.
Medicis Pharmaceutical Corp.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.